Are you Dr. Vanasse?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 90 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Karp 5.216
Boston, MA 02115Phone+1 617-732-5840Fax+1 617-732-5706
Summary
- Dr. K. Vanasse, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Dana-Farber Cancer Institute and is an Assistant Professor of Medicine at Brigham and Women's Hospital.
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 1996 - 1998
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1992 - 1995
- Georgetown University School of MedicineClass of 1992
Certifications & Licensure
- MA State Medical License 2007 - 2016
Publications & Presentations
PubMed
- 352 citationsThe allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1Andrew Wylie, Joseph Schoepfer, Wolfgang Jahnke, Sandra W. Cowan-Jacob, Alice Loo
Nature. 2017-03-30 - 43 citationsThe first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myelomaMarc S. Raab, Sheeba K. Thomas, Enrique M. Ocio, Andreas Guenther, Yeow Tee Goh
Leukemia. 2019-12-01 - 60 citationsIdentification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Inser...Matthew Burger, Gisele Nishiguchi, Wooseok Han, Jiong Lan, Robert Lowell Simmons
Journal of Medicinal Chemistry. 2015-10-27